Immobilase began with an accident in the lab.

During her PhD at University College London, Amy was exploring 3D printing for enzyme-controlled drug delivery when she stumbled on something unexpected.

After loading enzymes onto a 3D-printed scaffold, she left the construct out at room temperature for a month, assuming the enzymes would be inactive. On a whim, she tested it anyway. To her surprise, it still worked.

That single moment sparked a deeper investigation. She began testing the limits of the method, pushing for stability, reusability, and speed.

Today, we’ve successfully immobilised a range of enzymes and kept them active for over eight months (and counting). Together with her academic advisors Helen, Steve, and Jack, Amy transformed a serendipitous discovery into a robust, scalable enzyme immobilisation technology.